CIPROGIFT

This brand name is authorized in Nigeria.

Active ingredients

The drug CIPROGIFT contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 5E8K9I0O4U - CIPROFLOXACIN
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1842	Intravenous infusion	Ciprogift Infusion INJ_SOL 200 mg/100 mL 1 x 100 mL	77 CIPROGIFT INFUSION CIPROGIFT CIPROFLOXACIN CIPROFLOXACIN 200MG/100ML PRESCRIPTION ONLY MEDICINE INFUSION 1 X 100ML ANTIBIOTICS MARK PHARMACEUTICALS LIMITED "6, ADEMULEGUN STREET, IRE-AKARI ESTATE, ISOLO, LAGOS STATE. " AHLCON PARENTERALS (INDIA) LTD SP 917-918, PHASE-III RIICO IND AREA BHIWADI-301019 DIST ALWAR RAJASTHAN INDIA C4-1842 TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE MICRO-ORGANISMS 09/28/2021 09/27/2026	28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1842